These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37089814)

  • 1.
    Zhang Z; Lu Y; Vosoughi S; Levy JJ; Christensen BC; Salas LA
    NAR Cancer; 2023 Jun; 5(2):zcad017. PubMed ID: 37089814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
    Liu H; Qiu C; Wang B; Bing P; Tian G; Zhang X; Ma J; He B; Yang J
    Front Cell Dev Biol; 2021; 9():619330. PubMed ID: 34012960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Cancer DNA Methylation Analysis and Tumor Origin Identification of Carcinoma of Unknown Primary Site Based on Multi-Omics.
    Liu P
    Front Genet; 2021; 12():798748. PubMed ID: 35069697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-based deep learning model using DNA methylation data predicts the origin of cancer of unknown primary.
    Hwang J; Lee Y; Yoo SK; Kim JI
    Neoplasia; 2024 Sep; 55():101021. PubMed ID: 38943996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PathMethy: an interpretable AI framework for cancer origin tracing based on DNA methylation.
    Xie J; Song Y; Zheng H; Luo S; Chen Y; Zhang C; Yu R; Tong M
    Brief Bioinform; 2024 Sep; 25(6):. PubMed ID: 39391931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
    Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W
    Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Fast, Affordable, and Minimally Invasive Diagnostic Test for Cancer of Unknown Primary Using DNA Methylation Profiling.
    De Wilde J; Van Paemel R; De Koker A; Roelandt S; Van de Velde S; Callewaert N; Van Dorpe J; Creytens D; De Wilde B; De Preter K
    Lab Invest; 2024 Aug; 104(8):102091. PubMed ID: 38830578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck cancer of unknown primary: unveiling primary tumor sites through machine learning on DNA methylation profiles.
    Stark L; Kasajima A; Stögbauer F; Schmidl B; Rinecker J; Holzmann K; Färber S; Pfarr N; Steiger K; Wollenberg B; Ruland J; Winter C; Wirth M
    Clin Epigenetics; 2024 Mar; 16(1):47. PubMed ID: 38528631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation.
    He B; Dai C; Lang J; Bing P; Tian G; Wang B; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165916. PubMed ID: 32771416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue of origin prediction for cancer of unknown primary using a targeted methylation sequencing panel.
    Sun M; Xu B; Chen C; Zhu Y; Li X; Chen K
    Clin Epigenetics; 2024 Feb; 16(1):25. PubMed ID: 38336771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine Learning Approaches to Classify Primary and Metastatic Cancers Using Tissue of Origin-Based DNA Methylation Profiles.
    Modhukur V; Sharma S; Mondal M; Lawarde A; Kask K; Sharma R; Salumets A
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the classifiers based on mRNA, microRNA and lncRNA expression and DNA methylation profiles for the tumor origin detection.
    Feng Y; Wang Y
    Front Genet; 2024; 15():1383852. PubMed ID: 38933920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Machine Learning Classifier for Brain Tumors Diagnosis Based on DNA Methylation Profile.
    Chen Y; Yan Y; Xu M; Chen W; Lin J; Zhao Y; Wu J; Wang X
    Front Bioinform; 2021; 1():744345. PubMed ID: 36303797
    [No Abstract]   [Full Text] [Related]  

  • 15. HiTIMED: hierarchical tumor immune microenvironment epigenetic deconvolution for accurate cell type resolution in the tumor microenvironment using tumor-type-specific DNA methylation data.
    Zhang Z; Wiencke JK; Kelsey KT; Koestler DC; Christensen BC; Salas LA
    J Transl Med; 2022 Nov; 20(1):516. PubMed ID: 36348337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting cancer origins with a DNA methylation-based deep neural network model.
    Zheng C; Xu R
    PLoS One; 2020; 15(5):e0226461. PubMed ID: 32384093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Learning-Based Identification of Tissue of Origin for Carcinomas of Unknown Primary Using MicroRNA Expression: Algorithm Development and Validation.
    Raghu A; Raghu A; Wise JF
    JMIR Bioinform Biotechnol; 2024 Jul; 5():e56538. PubMed ID: 39046787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen.
    Marquard AM; Birkbak NJ; Thomas CE; Favero F; Krzystanek M; Lefebvre C; Ferté C; Jamal-Hanjani M; Wilson GA; Shafi S; Swanton C; André F; Szallasi Z; Eklund AC
    BMC Med Genomics; 2015 Oct; 8():58. PubMed ID: 26429708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care.
    Penson A; Camacho N; Zheng Y; Varghese AM; Al-Ahmadie H; Razavi P; Chandarlapaty S; Vallejo CE; Vakiani E; Gilewski T; Rosenberg JE; Shady M; Tsui DWY; Reales DN; Abeshouse A; Syed A; Zehir A; Schultz N; Ladanyi M; Solit DB; Klimstra DS; Hyman DM; Taylor BS; Berger MF
    JAMA Oncol; 2020 Jan; 6(1):84-91. PubMed ID: 31725847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A second-generation microRNA-based assay for diagnosing tumor tissue origin.
    Meiri E; Mueller WC; Rosenwald S; Zepeniuk M; Klinke E; Edmonston TB; Werner M; Lass U; Barshack I; Feinmesser M; Huszar M; Fogt F; Ashkenazi K; Sanden M; Goren E; Dromi N; Zion O; Burnstein I; Chajut A; Spector Y; Aharonov R
    Oncologist; 2012; 17(6):801-12. PubMed ID: 22618571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.